Skip to main content

Table 1 Primary outcome measure

From: OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study

 

Dropped out

Non responders

Responders

Proportion of responders

ITT analysis

Per-protocol analysis

N

6

16

41

65.1%

72%

  1. ITT Intention To Treat
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us